(Toronto, June 27, 2024) JMIR Publications is pleased to announce that JMIR Cancer has received a Journal Impact Factor (JIF) of 3.3 as published in the 2024 Journal Citation Report (JCR) from Clarivate. This follows our recent announcement that according to Scopus CiteScore, JMIR Cancer is also a Q2 journal in their “Oncology” category.

Here’s a selection of some of the highly cited articles from JMIR Cancer:

Chatbot for Health Care and Oncology Applications Using Artificial Intelligence and Machine Learning: Systematic Review
Using Social Media for Peer-to-Peer Cancer Support: Interviews With Young Adults With Cancer
A Home-Based Mobile Health Intervention to Replace Sedentary Time With Light Physical Activity in Older Cancer Survivors: Randomized Controlled Pilot Trial

Overall, 8 JMIR Publications journals (more than half of our portfolio of journals with a JIF) secured positions in the top quartile of their respective categories.

A Complete List of JMIR Publications Titles With a JIF in 2024:

Journal of Medical Internet Research	5.8	Q1
JMIR mHealth and uHealth	5.4	Q1
JMIR Aging	5.0	Q1
JMIR Mental Health	4.8	Q1
JMIR Serious Games	3.8	Q1
JMIR Infodemiology	3.5	Q1
JMIR Public Health and Surveillance	3.5	Q1
JMIR Cancer	3.3	Q2
JMIR Medical Education	3.2	Q1
JMIR Medical Informatics	3.1	Q2
JMIR Human Factors	2.6	Q2
JMIR Pediatrics and Parenting	2.1	Q2
JMIR Formative Research	2.0
Interactive Journal of Medical Research	1.9
JMIR Research Protocols	1.4

For 25 years, JMIR Publications has been advocating for open access in digital health. Discover our complete open access journal portfolio and explore the communities progressing digital health and health research in the internet age.

We are grateful to the scholars, researchers, institutions, funders, peer reviewers, editors, and editorial board members who have contributed to our mission of advancing scientific knowledge.

Submit your paper now to JMIR Cancer.

This paper is in the following e-collection/theme issue:

A Mobile Breast Cancer Survivorship Care App: Pilot Study

A Mobile Breast Cancer Survivorship Care App: Pilot Study